Work

The era of GLP-1 receptor agonists: costs versus benefits

Year: 2024

Type: editorial

Source: The Lancet Diabetes & Endocrinology

DOI: 10.1016/s2213-8587(24)00376-0

Author: The Lancet Diabetes & Endocrinology

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4405267348

Cites:

Cited by: 11

Related to: 10